Literature DB >> 16367746

Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus.

Hugues Bedouelle1, Laurent Belkadi, Patrick England, J Iñaki Guijarro, Olesia Lisova, Agathe Urvoas, Muriel Delepierre, Philippe Thullier.   

Abstract

Dengue is a re-emerging viral disease, affecting approx. 100 million individuals annually. The monoclonal antibody mAb4E11 neutralizes the four serotypes of the dengue virus, but not other flaviviruses. Its epitope is included within the highly immunogenic domain 3 of the envelope glycoprotein E. To understand the favorable properties of recognition between mAb4E11 and the virus, we recreated the genetic events that led to mAb4E11 during an immune response and performed an alanine scanning mutagenesis of its third hypervariable loops (H-CDR3 and L-CDR3). The affinities between 16 mutant Fab fragments and the viral antigen (serotype 1) were measured by a competition ELISA in solution and their kinetics of interaction by surface plasmon resonance. The diversity and junction residues of mAb4E11 (D segment; V(H)-D, D-J(H) and V(L)-J(L) junctions) constituted major hotspots of interaction energy. Two residues from the D segment (H-Trp96 and H-Glu97) provided > 85% of the free energy of interaction and were highly accessible to the solvent in a three-dimensional model of mAb4E11. Changes of residues (L-Arg90 and L-Pro95) that statistically do not participate in the contacts between antibodies and antigens but determine the structure of L-CDR3, decreased the affinity between mAb4E11 and its antigen. Changes of L-Pro95 and other neutral residues strongly decreased the rate of association, possibly by perturbing the topology of the electrostatic field of the antibody. These data will help to improve the properties of mAb4E11 for therapeutic applications and map its epitope precisely.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16367746     DOI: 10.1111/j.1742-4658.2005.05045.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  10 in total

1.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 2.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

3.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

4.  Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.

Authors:  Julia C Frei; Margaret Kielian; Jonathan R Lai
Journal:  Virology       Date:  2015-09-02       Impact factor: 3.616

5.  Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

Authors:  Kannan Tharakaraman; Luke N Robinson; Andrew Hatas; Yi-Ling Chen; Liu Siyue; S Raguram; V Sasisekharan; Gerald N Wogan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

6.  A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III.

Authors:  Dan Hu; Zhongyu Zhu; Shun Li; Yongqiang Deng; Yanling Wu; Nana Zhang; Vinita Puri; Chunyu Wang; Peng Zou; Cheng Lei; Xiaolong Tian; Yulu Wang; Qi Zhao; Wei Li; Ponraj Prabakaran; Yang Feng; Jane Cardosa; Chengfeng Qin; Xiaohui Zhou; Dimiter S Dimitrov; Tianlei Ying
Journal:  PLoS Pathog       Date:  2019-06-26       Impact factor: 6.823

7.  Antibody germline characterization of cross-neutralizing human IgGs against 4 serotypes of dengue virus.

Authors:  Pannamthip Pitaksajjakul; Surachet Benjathummarak; Chonlatip Pipattanaboon; Waranya Wongwit; Tamaki Okabayashi; Motoki Kuhara; Ryo Misaki; Kazuhito Fujiyama; Pongrama Ramasoota
Journal:  Biochem Biophys Res Commun       Date:  2014-03-14       Impact factor: 3.575

8.  Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Authors:  Karnpob Kanhasut; Kannan Tharakaraman; Mathuros Ruchirawat; Jutamaad Satayavivad; Mayuree Fuangthong; Ram Sasisekharan
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

9.  Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus.

Authors:  Samantha Brandler; Marianne Lucas-Hourani; Arnaud Moris; Marie-Pascale Frenkiel; Chantal Combredet; Michèle Février; Hugues Bedouelle; Olivier Schwartz; Philippe Desprès; Frédéric Tangy
Journal:  PLoS Negl Trop Dis       Date:  2007-12-12

10.  The folded and disordered domains of human ribosomal protein SA have both idiosyncratic and shared functions as membrane receptors.

Authors:  Nora Zidane; Mohamed B Ould-Abeih; Isabelle Petit-Topin; Hugues Bedouelle
Journal:  Biosci Rep       Date:  2012-12-20       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.